|
|
Zhi Huang, Sruti Shiva, Daniel B. Kim-Shapiro, Rakesh P. Patel, Lorna A. Ringwood, Cynthia E. Irby, Kris T. Huang, Chien Ho, Neil Hogg, Alan N. Schechter, Mark T. Gladwin
J Clin Invest. 2005;
115(8):2099
doi:10.1172/JCI24650
Abstract |
Full text
| PDF

H
ypoxic vasodilation is a fundamental, highly conserved physiological response that requires oxygen and/or pH sensing coupled to vasodilation. While this process was first characterized more than 80 years ago, the precise identity and mechanism of the oxygen sensor and mediators of vasodilation remain uncertain. In support of a possible role for hemoglobin (Hb) as a sensor and effector of hypoxic vasodilation, here we show biochemical evidence that Hb exhibits enzymatic behavior as a nitrite reductase, with maximal NO generation rates occurring near the oxy-to-deoxy (R-to-T) allosteric structural transition of the protein. The observed rate of nitrite reduction by Hb deviates from second-order kinetics, and sigmoidal reaction progress is determined by a balance between 2 opposing chemistries of the heme in the R (oxygenated conformation) and T (deoxygenated conformation) allosteric quaternary structures of the Hb tetramer — the greater reductive potential of deoxyheme in the R state tetramer and the number of unligated deoxyheme sites necessary for nitrite binding, which are more plentiful in the T state tetramer. These opposing chemistries result in a maximal nitrite reduction rate when Hb is 40–60% saturated with oxygen (near the Hb P50), an apparent ideal set point for hypoxia-responsive NO generation. These data suggest that the oxygen sensor for hypoxic vasodilation is determined by Hb oxygen saturation and quaternary structure and that the nitrite reductase activity of Hb generates NO gas under allosteric and pH control.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(109)
| Title and authors |
Publication |
Year |
Nitrite reduction by CoII and MnII substituted myoglobins
Julie L. Heinecke, Jun Yi, Jose Clayston Melo Pereira, George B. Richter-Addo, Peter C. Ford
|
Journal of Inorganic Biochemistry
|
2012 |
Plasma methemoglobin as a potential biomarker of anemic stress in humans
Gregory M. T. Hare, Alexander Mu, Alexander Romaschin, Albert K.-Y. Tsui, Nadine Shehata, W. Scott Beattie, C. David Mazer
|
Canadian Journal of Anesthesia
|
2012 |
Hypotensive Effect of Oxacom® Containing a Dinitrosyl Iron Complex with Glutathione: Animal Studies And Clinical Trials On healthy Volunteers
Evgeny I. Chazov, Oleg V. Rodnenkov, Andrey V. Zorin, Vladimir L. Lakomkin, Vladimir V. Gramovich, Oleg N. Vyborov, Anatoly G. Dragnev, Аlexander А. Timoshin, Lyudmila I. Buryachkovskaya, Alexander A. Abramov
|
Nitric Oxide
|
2012 |
Nitrite and Nitrite Reductases: From Molecular Mechanisms to Significance in Human Health and Disease
Nicoletta Castiglione, Serena Rinaldo, Giorgio Giardina, Valentina Stelitano, Francesca Cutruzzolà
|
Antioxidant Redox Signal
|
2012 |
Oxygen Regulates Tissue Nitrite Metabolism
Erin Curtis, Lewis L. Hsu, Audrey C. Noguchi, Lisa Geary, Sruti Shiva
|
Antioxidant Redox Signal
|
2012 |
Comprehensive Physiology
Allan Doctor, Jonathan S. Stamler
|
Comprehensive Physiology
|
2011 |
Chemistry and Biochemistry of Oxygen Therapeutics
Tim J. McMahon, Joseph Bonaventura
|
Chemistry and Biochemistry of Oxygen Therapeutics
|
2011 |
Inorganic nitrite therapy: historical perspective and future directions
Christopher G. Kevil, Gopi K. Kolluru, Christopher B. Pattillo, Tony Giordano
|
Free Radical Biology and Medicine
|
2011 |
Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats
Matthew J. Alef, Raghuveer Vallabhaneni, Evie Carchman, Sidney M. Morris Jr., Sruti Shiva, Yinna Wang, Eric E. Kelley, Margaret M. Tarpey, Mark T. Gladwin, Edith Tzeng, Brian S. Zuckerbraun
|
J. Clin. Invest.
|
2011 |
Effect of hemoglobin on the NO-donor ability of μ2-S-bis(pyrimidine-2-thiolato)tetranitrosyldiiron
L. A. Syrtsova, N. A. Sanina, A. F. Shestakov, N. I. Shkondina, T. N. Rudneva, N. S. Emel’yanova, A. I. Kotel’nikov, S. M. Aldoshin
|
Russ Chem Bull
|
2011 |
|